Germany
Japan
United Kingdom
China
Antibodies
ALK mouse monoclonal antibody, clone OTI1A4
| Applications | IHC, LMNX, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
.jpg?d=110x100 "User supplied image")
Tyrosine Hydroxylase (TH) mouse monoclonal antibody, clone LNC1
| Applications | IF, IHC, WB |
| Reactivities | All Species |
| Conjugation | Unconjugated |
Rabbit monoclonal anti-PD-L1 Antibody, clone OR-5H8
| Applications | IHC |
| Reactivities | Human |
| Conjugation | Unconjugated |
Special Offer: Get this product for $99/€99. Use code: "Truesample".
Rabbit monoclonal anti-PD-L1 Antibody, clone OR-5E3
| Applications | IHC |
| Reactivities | Human |
| Conjugation | Unconjugated |
Special Offer: Get this product for $99/€99. Use code: "Truesample".
USD 479.00
2 Weeks
USD 379.00
In Stock
USD 428.00
In Stock
Rabbit Monoclonal Anti-Human IgG4 Antibody, Clone RM120
| Applications | ELISA: 50ng/well - 200ng/well for Capture;, 0.05ug/mL - 0.2ug/mL for Detection;, , WB: 0.5 ug/mL - 2 ug/mL;, ICC: 1 ug/mL-10ug/mL;, IHC: 1 ug/mL-10ug/mL |
| Reactivities | Human IgG4 |
| Conjugation | Unconjugated |
USD 379.00
In Stock
USD 428.00
In Stock
TGF beta 1 (TGFB1) mouse monoclonal antibody, clone TB21, Azide Free
| Applications | ELISA, FN, IHC, WB |
| Reactivities | Human, Sheep |
| Conjugation | Unconjugated |
Carrier-free (BSA/glycerol-free) TIGIT mouse monoclonal antibody, clone OTI8G7
| Applications | IHC |
| Reactivities | Human |
| Conjugation | Unconjugated |
TIGIT mouse monoclonal antibody, clone OTI8G7
| Applications | IHC |
| Reactivities | Human |
| Conjugation | Unconjugated |
Goat Monoclonal Anti-Mouse IgG Fc Antibody, Clone RMG06
| Applications | ELISA: 0.05ug/mL - 1ug/mL;, ICC, IHC: 0.5ug/mL - 2ug/mL;, WB: 0.1ug/mL - 0.5ug/mL |
| Reactivities | Mouse IgG |
| Conjugation | Unconjugated |
Active filters
Applications
- IHC
Clonalities
- Monoclonal
Conjugates
- Unconjugated
Filter by
Target Symbol
- MAP2K1 (103)
- NME1 (84)
- MKI67 (83)
- TP53 (83)
- KRT19 (82)
- MSMB (74)
- TG (72)
- PECAM1 (70)
- KLK8 (69)
- LIPG (69)
- OTC (69)
- ERBB2 (68)
- PGR (68)
- NBN (63)
- CD4 (60)
- CTAG1B (60)
- MAP2K3 (57)
- ABCB1 (51)
- CDKN2A (51)
- PTPRC (51)
- CD99 (50)
- EPCAM (50)
- LGALS3 (49)
- ADIPOQ (47)
- CHGA (47)
- CTNNB1 (45)
- ERCC1 (45)
- VSNL1 (45)
- NKX3-1 (44)
- PCNA (44)
- PIK3C2A (42)
- TOP2A (42)
- KRT20 (41)
- MLANA (41)
- PDCD1 (41)
- NCAM1 (40)
- MS4A1 (39)
- APP (38)
- BCL2 (38)
- CD44 (38)
- ABAT (37)
- CD68 (37)
- JUN (36)
- RTRAF (36)
- S100A9 (36)
- SENP2 (36)
- TYMP (36)
- EGFR (34)
- BBOX1 (33)
- KIT (33)
- MDM4 (33)
- MGMT (33)
- PROCR (33)
- VBP1 (33)
- AKT1 (32)
- KRT7 (32)
- MUC1 (32)
- AMACR (31)
- LTA4H (31)
- SYP (31)
- TYMS (31)
- ALDH1L1 (30)
- BSG (30)
- BUB1B (30)
- CD163 (30)
- CD40 (30)
- CDH1 (30)
- CTSL (30)
- FCGR2A (30)
- GBP2 (30)
- MCM2 (30)
- MEF2C (30)
- MGLL (30)
- NAPSA (30)
- NPR3 (30)
- PARVA (30)
- PDE4A (30)
- PFKP (30)
- PIK3CG (30)
- PPP5C (30)
- SERPINB3 (30)
- TNFRSF8 (30)
- UBE2G2 (30)
- BRDU (29)
- BTK (29)
- CR2 (29)
- L1CAM (29)
- SQSTM1 (29)
- AGR2 (28)
- CD63 (28)
- F13A1 (28)
- KRT18 (28)
- POR (28)
- RET (28)
- VWF (28)
- ACAT2 (27)
- AKR1A1 (27)
- BHLHE41 (27)
- DEF6 (27)
- FOLH1 (27)
Reactivities
- Human (19102)
- Mouse (11118)
- Rat (10738)
- Monkey (1727)
- Dog (1571)
- Bovine (40)
- Hamster (39)
- Primate (33)
- Porcine (30)
- Rabbit (24)
- Chicken (22)
- Sheep (22)
- Canine (21)
- Xenopus (20)
- Pig (18)
- Zebrafish (17)
- Guinea Pig (13)
- Chimpanzee (10)
- Drosophila (10)
- Cow (9)
- Feline (8)
- Goat (6)
- Equine (5)
- All Species (4)
- Cynomolgus (4)
- Yeast (4)
- Baboon (3)
- C. elegans (3)
- Fish (3)
- Macaque (3)
- Marmoset (3)
- Dengue virus (2)
- Ferret (2)
- Mammalian (2)
- Plant (2)
- Virus (2)
- West Nile Virus (2)
- Yellow Fever Virus (2)
- Beluga (1)
- Carp (1)
- Drosophila melanogaster (1)
- Escherichia coli (1)
- Frog (1)
- Fungi (1)
- Helicobacter pylori (1)
- Insect (1)
- Salmonella Typhimurium (1)
- Spinach (1)
- Squirrel (1)
- Trichinella spiralis (1)
- Vertebrates (1)
- White Fly (1)
Antibody Hosts
Isotypes
- IgG1 (11914)
- IgG2a (3392)
- IgG2b (2927)
- IgG (558)
- IgG1, kappa (231)
- IgG, kappa (133)
- IgG2a, kappa (76)
- IgG3 (56)
- IgG2b, kappa (52)
- IgM (11)
- IgG3, kappa (10)
- IgM, kappa (9)
- IgG1, lambda (8)
- IgG2c (4)
- IgG2 (2)
- IgG2, kappa (2)
- IgG2a, lambda (2)
- IgG2b, lambda (2)
- IgA, kappa (1)
- IgG fraction (1)
- IgG1/IgK (1)
- IgG12b (1)
- IgG4 (1)
- cocktail (1)
Carrier-free
Knockout (KO) Validation
Modifications
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG1 format, for improved compatibility with existing reagents, assays and techniques. (37)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Rat IgG2a format, for improved compatibility with existing reagents, assays and techniques. (16)
- This chimeric rabbit antibody was made using the variable domain sequences of the original murine IgG1 format, for improved compatibility with existing reagents, assays and techniques. (11)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Rat IgG2b format, for improved compatibility with existing reagents, assays and techniques. (9)
- This chimeric rabbit antibody was made using the variable domain sequences of the original murine IgG2a format, for improved compatibility with existing reagents, assays and techniques. (8)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG2a format, for improved compatibility with existing reagents, assays and techniques. (7)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. (6)
- Phospho-specific (6)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG2b format, for improved compatibility with existing reagents, assays and techniques. (6)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques. (5)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Rat IgG1 format, for improved compatibility with existing reagents, assays and techniques. (5)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgM format, for improved compatibility with existing reagents, assays and techniques. (4)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This is a chimeric antibody created for improved compatibility with existing reagents, assays and techniques. (3)
- This chimeric mouse antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques. (3)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Hamster IgG format, for improved compatibility with existing reagents, assays and techniques. (3)
- This chimeric rabbit antibody was made using the variable domain sequences of the original rat IgG2a format, for improved compatibility with existing reagents, assays and techniques. (3)
- This chimeric rabbit antibody was made using the variable domain sequences of the original format, for improved compatibility with existing reagents, assays and techniques. (2)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG3 format, for improved compatibility with existing reagents, assays and techniques. (2)
- This constant region of this antibody has been modified to bind to Protein A, allowing highly-specific purification of this antibody by Protein A-affinity column. (2)
- This full-length, chimeric rabbit antibody was made using the variable domain sequences of the original Human scFv format, for improved compatibility with existing reagents, assays and techniques. (2)
- This full-length, reformatted human antibody was made using the variable domain sequences of the original Human scFv format, for improved compatibility with existing reagents, assays and techniques. (2)
- This is a chimeric antibody created for improved compatibility with existing reagents, assays and techniques. (2)
- This reformatted mouse antibody was made using the variable domain sequences of the original Mouse IgG format, for improved compatibility with existing reagents, assays and techniques. (2)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This chimeric mouse antibody was made using the variable domain sequences of the original Human IgG4 (primatized) format, for improved compatibility with existing reagents, assays and techniques. (1)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This chimeric mouse antibody was made using the variable domain sequences of the original Human IgG4 format, for improved compatibility with existing reagents, assays and techniques. (1)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgG4 (primatized) format, for improved compatibility with existing reagents, assays and techniques. (1)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgG4 format, for improved compatibility with existing reagents, assays and techniques. (1)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This chimeric rabbit antibody was made using the variable domain sequences of the original human IgG1 format, for improved compatibility with existing reagents, assays and techniques. (1)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This reformatted human antibody was made using the variable domain sequences of the original Human IgG4 (primatized) format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric human antibody was made using the variable domain sequences of the original Mouse IgG2a format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric mouse antibody was made using the variable domain sequences of the original Human format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Armenian Hamster IgG format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Armenian Hamster IgG format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Human format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgG4 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgM format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG2 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse scFv antibody fragment format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original human IgG1 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original human scFv format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original murine IgG2b format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original rat IgG1 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original rat IgG2b format, for improved compatibility with existing reagents, assays and techniques. (1)
- This is a chimeric antibody created to reduce immunogenicity during in vivo applications. (1)
- This is a chimeric mouse antibody, based on the original rat IgG2b format, created for improved compatibility with existing reagents, assays and techniques. (1)
- This reformatted mouse antibody was made using the variable domain sequences of the original Mouse format, for improved compatibility with existing reagents, assays and techniques. (1)
- This reformatted mouse antibody was made using the variable domain sequences of the original Mouse IgG2a format, for improved compatibility with existing reagents, assays and techniques. (1)
- This reformatted mouse antibody was made using the variable domain sequences of the original Mouse IgG3 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This reformatted mouse antibody was made using the variable domain sequences of the original Mouse scFv antibody fragment format, for improved compatibility with existing reagents, assays and techniques. (1)
Assay Types
Families
- Druggable Genome (10729)
- Transmembrane (3439)
- Transcription Factors (2559)
- Secreted Protein (1684)
- ES Cell Differentiation/IPS (1617)
- Protein Kinase (1156)
- Protease (874)
- Stem cell - Pluripotency (827)
- Adult stem cells (347)
- Nuclear Hormone Receptor (219)
- Embryonic stem cells (210)
- Phosphatase (172)
- Cancer stem cells (155)
- P450 (134)
- Induced pluripotent stem cells (105)
- Stem cell relevant signaling - DSL/Notch pathway (103)
- Stem cell relevant signaling - JAK/STAT signaling pathway (77)
- Ion Channels: Other (59)
- GPCR (42)
- Stem cell relevant signaling - TGFb/BMP signaling pathway (36)
- Ion Channels: Potassium (15)
- Ion Channels: Transient receptor potential (14)
- Stem cell relevant signaling - Wnt Signaling pathway (13)
- Ion Channels: Cys-loop Receptors (10)
- Ion Channels: Calcium (2)
- Ion Channels: Sodium (2)
- Ion Channels: Glutamate Receptors (1)
Pathways
- Metabolic pathways (2140)
- Pathways in cancer (1368)
- MAPK signaling pathway (766)
- Prostate cancer (737)
- Focal adhesion (735)
- Cell adhesion molecules (CAMs) (621)
- Colorectal cancer (620)
- T cell receptor signaling pathway (599)
- Melanoma (577)
- Neurotrophin signaling pathway (569)
- Toll-like receptor signaling pathway (566)
- Endometrial cancer (562)
- Pancreatic cancer (559)
- Bladder cancer (553)
- ErbB signaling pathway (547)
- Glioma (539)
- Non-small cell lung cancer (531)
- Chronic myeloid leukemia (521)
- B cell receptor signaling pathway (511)
- Hematopoietic cell lineage (494)
- Insulin signaling pathway (474)
- Regulation of actin cytoskeleton (466)
- Progesterone-mediated oocyte maturation (457)
- Fc epsilon RI signaling pathway (435)
- Cell cycle (419)
- Fc gamma R-mediated phagocytosis (419)
- Acute myeloid leukemia (416)
- Apoptosis (414)
- Renal cell carcinoma (404)
- Leukocyte transendothelial migration (361)
- Thyroid cancer (359)
- Cytokine-cytokine receptor interaction (351)
- Natural killer cell mediated cytotoxicity (349)
- Chemokine signaling pathway (339)
- GnRH signaling pathway (339)
- Small cell lung cancer (337)
- p53 signaling pathway (327)
- Wnt signaling pathway (324)
- Endocytosis (323)
- VEGF signaling pathway (317)
- Pyrimidine metabolism (315)
- Purine metabolism (312)
- Alzheimer's disease (308)
- Jak-STAT signaling pathway (302)
- Amyotrophic lateral sclerosis (ALS) (297)
- Melanogenesis (292)
- Adherens junction (287)
- Oocyte meiosis (287)
- Gap junction (281)
- Huntington's disease (266)
- Type II diabetes mellitus (250)
- Primary immunodeficiency (241)
- Prion diseases (230)
- Glycolysis / Gluconeogenesis (229)
- mTOR signaling pathway (228)
- Adipocytokine signaling pathway (226)
- Arginine and proline metabolism (216)
- Pathogenic Escherichia coli infection (212)
- Ubiquitin mediated proteolysis (205)
- Vascular smooth muscle contraction (202)
- Long-term depression (196)
- Parkinson's disease (196)
- Calcium signaling pathway (195)
- Lysosome (195)
- Basal cell carcinoma (194)
- Complement and coagulation cascades (192)
- Long-term potentiation (191)
- Valine (184)
- leucine and isoleucine degradation (184)
- Antigen processing and presentation (179)
- Glycerolipid metabolism (177)
- Epithelial cell signaling in Helicobacter pylori infection (173)
- Nucleotide excision repair (171)
- Dorso-ventral axis formation (159)
- Drug metabolism - cytochrome P450 (157)
- Phosphatidylinositol signaling system (151)
- Tight junction (151)
- Autoimmune thyroid disease (150)
- Metabolism of xenobiotics by cytochrome P450 (149)
- Tryptophan metabolism (149)
- Fatty acid metabolism (146)
- Systemic lupus erythematosus (145)
- Axon guidance (141)
- Oxidative phosphorylation (139)
- Lysine degradation (136)
- Arachidonic acid metabolism (131)
- Inositol phosphate metabolism (129)
- ECM-receptor interaction (128)
- Propanoate metabolism (128)
- RIG-I-like receptor signaling pathway (128)
- Mismatch repair (125)
- PPAR signaling pathway (125)
- DNA replication (124)
- Alanine (121)
- Butanoate metabolism (121)
- aspartate and glutamate metabolism (121)
- Dilated cardiomyopathy (120)
- Hypertrophic cardiomyopathy (HCM) (117)
- Cytosolic DNA-sensing pathway (116)
- TGF-beta signaling pathway (116)
- RNA degradation (115)
- Glutathione metabolism (110)
- Retinol metabolism (108)
- Viral myocarditis (107)
- Histidine metabolism (106)
- Spliceosome (106)
- Tyrosine metabolism (106)
- Base excision repair (105)
- Type I diabetes mellitus (105)
- One carbon pool by folate (104)
- Arrhythmogenic right ventricular cardiomyopathy (ARVC) (99)
- NOD-like receptor signaling pathway (99)
- Glycine (98)
- serine and threonine metabolism (98)
- Pyruvate metabolism (96)
- Renin-angiotensin system (93)
- beta-Alanine metabolism (85)
- Homologous recombination (84)
- Allograft rejection (81)
- Proteasome (81)
- Hedgehog signaling pathway (77)
- ABC transporters (76)
- Pentose phosphate pathway (76)
- Starch and sucrose metabolism (74)
- Cardiac muscle contraction (73)
- Drug metabolism - other enzymes (72)
- Graft-versus-host disease (69)
- Linoleic acid metabolism (67)
- Amino sugar and nucleotide sugar metabolism (66)
- Cysteine and methionine metabolism (66)
- Circadian rhythm - mammal (65)
- Neuroactive ligand-receptor interaction (62)
- Notch signaling pathway (61)
- Vibrio cholerae infection (60)
- Terpenoid backbone biosynthesis (58)
- Fructose and mannose metabolism (57)
- Fatty acid elongation in mitochondria (54)
- Nicotinate and nicotinamide metabolism (54)
- Galactose metabolism (51)
- Primary bile acid biosynthesis (51)
- Sulfur metabolism (51)
- Caffeine metabolism (47)
- Folate biosynthesis (47)
- Nitrogen metabolism (47)
- Citrate cycle (TCA cycle) (46)
- Aminoacyl-tRNA biosynthesis (45)
- Maturity onset diabetes of the young (43)
- Sphingolipid metabolism (42)
- N-Glycan biosynthesis (39)
- Asthma (36)
- SNARE interactions in vesicular transport (36)
- Synthesis and degradation of ketone bodies (36)
- Glycerophospholipid metabolism (35)
- Other glycan degradation (33)
- Regulation of autophagy (33)
- RNA polymerase (30)
- Methane metabolism (28)
- Ribosome (28)
- Porphyrin and chlorophyll metabolism (27)
- Selenoamino acid metabolism (27)
- Non-homologous end-joining (26)
- Phenylalanine metabolism (26)
- Glyoxylate and dicarboxylate metabolism (25)
- Taste transduction (21)
- Cyanoamino acid metabolism (18)
- Glycosaminoglycan degradation (18)
- Androgen and estrogen metabolism (16)
- Ascorbate and aldarate metabolism (16)
- Limonene and pinene degradation (15)
- Pantothenate and CoA biosynthesis (15)
- Steroid biosynthesis (13)
- Biosynthesis of unsaturated fatty acids (12)
- Fatty acid biosynthesis (12)
- Vitamin B6 metabolism (12)
- Olfactory transduction (10)
- Ether lipid metabolism (9)
- Glycosphingolipid biosynthesis - ganglio series (9)
- Pentose and glucuronate interconversions (9)
- Taurine and hypotaurine metabolism (9)
- Riboflavin metabolism (7)
- D-Glutamine and D-glutamate metabolism (6)
- Glycosphingolipid biosynthesis - lacto and neolacto series (6)
- Keratan sulfate biosynthesis (6)
- O-Glycan biosynthesis (6)
- Thiamine metabolism (6)
- C21-Steroid hormone metabolism (4)
- Basal transcription factors (3)
- Biotin metabolism (3)
- Glycosphingolipid biosynthesis - globo series (3)
- Protein export (3)
- leucine and isoleucine biosynthesis (3)
- Chondroitin sulfate biosynthesis (1)
- Heparan sulfate biosynthesis (1)